Despite major advances in the treatment of metastatic melanoma, including targeted therapy with BRAF inhibitors or immune checkpoint blockade, malignant melanoma remains the skin tumor responsible for the highest number of skin tumor-associated deaths worldwide, with approximately 55,500 cases [2]. The gene discussed is BRAF; the disease is skin neoplasm.